Inhibitory effect of endostar in combination with radiotherapy in a mouse model of human CNE2 nasopharyngeal carcinoma

Abstract

The inhibitory effects of Endostar in combination with radiotherapy in BALB/c nude mice model of human CNE2 nasopharyngeal carcinoma and the mechanism were investigated. In nude mice model of CNE2 nasopharyngeal carcinoma, the inhibitory rate and the sensitizing enhancement ratio (E/O) were calculated according to the tumor volumes in different groups. The expression of microvascular density (MVD) in tumor tissues was examined by using immunohistochemistry staining. The transcription of VEGF gene was detected by using RT-PCR. The inhibitory rate in Endostar+ radiotherapy group was higher than in other groups. In Endostar+radiotherapy group, the tumor volume was significantly decreased and the E/O ratio was 2.335, suggesting that Endostar could be a radiosensitizer. The expression of MVD of tumor tissues in Endostar+radiotherapy group was reduced significantly. The expression of the MVD in treatment groups was significantly different from that in control group (P<0.05). Compared to other groups, VEGF mRNA expression in Endostar+radiotherapy group was decreased remarkably. Endostar in combination with radiotherapy significantly inhibited the growth of CNE2 tumor. The combination therapy decreased the expression of VEGF, and inhibited tumor angiogenesis and proliferation. When combined with radiotherapy, Endostar acted as a radiosensitizer.

Keywords

Endostar / radiotherapy / microvascular density / vascular endothelial growth factor

References

[1] WangJ.W., LiuY., LiuY.Y.. Results of randomized, multi-center, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients. Zhongguo Feiai Zazhi (Chinese), 2005, 8(4): 283-290

[2] SundM., HamanoY., SugimotoH., et al.. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci U S A, 2005, 102(8): 2934-2939

[3] TangL.P., XuX.Y., LouG.. Radiosensitizing effect of CPT-11 on cervical carcinoma transplanted tumor in nude mice. Zhongguo Xiandai Yixue Zazhi (Chinese), 2006, 16(22): 3368-3370

[4] WenQ.L., MengM.B., YangB., et al.. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice. Cancer Sci, 2009, 100(8): 1510-1519

[5] MauceriH.J., HannaN.N., BeckettM.A., et al.. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature, 1998, 394(6690): 287-291

[6] ShiW., TeschendorfC., MuzyczkaN., et al.. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol, 2003, 66(1): 1-9

[7] LuoX., SlaterJ.M., GridleyD.S.. Radiation and endostatin gene therapy in a lung carcinoma model: pilot data on cells and cytokines that affect angiogenesis and immune status. Technol Cancer Res Treat, 2006, 5(2): 135-146

[8] LuoX., SlaterJ.M., GridleyD.S.. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model. Int J Radiat Oncol Biol Phys, 2005, 63(2): 553-564

[9] ReisR.C., SchuppanD., BarretoA.C., et al.. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. Biochem Biophys Res Commun, 2005, 333(3): 976-83

[10] HashizumeH., BalukP., MorikawaS., et al.. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol, 2000, 156(4): 1363-1380

[11] MorikawaP., BalukT., KaidohA., et al.. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol, 2002, 160(3): 985-1000

[12] WeberC.C., CaiH., EhrbarM., et al.. Effects of protein and gene transfer of the angiopoieti-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization. J Biol Chem, 2005, 280(23): 22 445-22 453

[13] JainR.K., MunnL.L., FukumuraD.. Dissecting tumor pathophysiology using intravital microscopy. Nat Rev Cancer, 2002, 2(4): 266-276

[14] JainR.K.. Determinants of tumor blood flow: a review. Cancer Res, 1988, 48(10): 2641-2658

[15] BussinkJ., KaandersJ.H., van der KogelA.J.. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol, 2003, 67(1): 3-15

[16] LeeC.G., HeijnM., di TomasoE.. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res, 2000, 60(19): 5565-5570

[17] JainR.K.. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 2005, 307(5706): 58-62